You have 9 free searches left this month | for more free features.

Dermatologic Life Qualify Index (DLQI)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Psoriasis Trial in Ghent (biological, procedure, other)

Completed
  • Psoriasis
  • Dose tapering of adalimumab in patients with supratheurapeutic serum trough levels
  • +4 more
  • Ghent, Belgium
    University Hospital
Jan 5, 2023

Quality of Life Assessment in Cancer Patients and Survivors With

Recruiting
  • Cancer
  • Dermatologic Conditions
  • Quality of Life (QoL) Assessment
  • Basking Ridge, New Jersey
  • +3 more
Jan 18, 2023

Pruritus, Uremia, Chronic Kidney Diseases Trial in Lahore (Loratadine, Gabapentin)

Completed
  • Pruritus
  • +2 more
  • Lahore, Punjab, Pakistan
    King Edward Medical University/Mayo Hospital
Mar 3, 2023

Treatment of Hypertrichosis With Intense Pulsed Light

Not yet recruiting
  • Hypertrichosis
  • Hirsutism - Hypertrichosis
  • Intense pulsed light
  • Umeå, Västerbotten, Sweden
    Norrlands University Hospital
Mar 20, 2023

Psoriasi Trial in Sohag (adalimumab and methotrexate)

Not yet recruiting
  • Psoriasi
  • adalimumab and methotrexate
  • Sohag, Egypt
    Sohag University Hospital
Jun 1, 2023

Urticaria Trial (desloratadine)

Completed
  • Urticaria
  • (no location specified)
Feb 7, 2022

Acquired Absence of Lower Limb, Scar Condition and Fibrosis of the Skin Trial in Miami, Tampa (Fractional CO2 Laser Ablative

Not yet recruiting
  • Acquired Absence of Lower Limb
  • Scar Condition and Fibrosis of the Skin
  • Fractional CO2 Laser Ablative Resurfacing
  • Miami, Florida
  • +1 more
Jul 25, 2023

Sensitivity and Specificity ofNovel Quality of Life Tool to

Recruiting
  • Psoriasis
  • DLQI and PSO-TARGET QoL grid
  • Bruxelles, Belgium
  • +26 more
Sep 20, 2021

CLINICAL EFFICACY OF EMOLLIENTS IN ATOPIC DERMATITIS PATIENTS

Completed
  • Atopic Dermatitis
  • Cosmetic study
  • Rio de Janeiro, Brazil
    CIDP
Mar 13, 2023

Skin Toxicity, Immunotoxicity Trial in Hasselt (Hydrating emollient + body lotion for immunotherapy-related side effects)

Recruiting
  • Skin Toxicity
  • Immunotoxicity
  • Hydrating emollient + body lotion for immunotherapy-related side effects
  • Hasselt, Limburg, Belgium
    Jessa Ziekenhuis VZW
Dec 2, 2021

Skin Toxicity Trial in Hasselt (Self-prepared emollient)

Recruiting
  • Skin Toxicity
  • Self-prepared emollient
  • Hasselt, Limburg, Belgium
    Jessa Ziekenhuis VZW
Dec 2, 2021

Cardiovascular Risk Predictors in Patients With Psoriasis

Recruiting
  • Psoriasis
  • Cardiovascular Diseases
    • Moscow, Russian Federation
      University Clinical Hospital #2
    Apr 20, 2022

    Atopic Dermatitis, Atopic Dermatitis Eczema Trial in San Francisco (Dupilumab)

    Completed
    • Atopic Dermatitis
    • Atopic Dermatitis Eczema
    • San Francisco, California
      UCSF Psoriasis and Skin Treatment Center
    Jan 5, 2023

    Radiodermatitis; Acute Trial in Cairo (Olive oil cream, Betamethasone Valerate Cream, Base Cream)

    Recruiting
    • Radiodermatitis; Acute
    • Olive oil cream
    • +2 more
    • Cairo, Egypt
      Ain Shams University Hospitals
    Mar 9, 2022

    Hidradenitis Suppurativa Mail Survey

    Active, not recruiting
    • Hidradenitis Suppurativa
      • Winston-Salem, North Carolina
        Wake Forest Baptist Medical Center
      Jun 28, 2022

      New Assessment Tool for Lichen Planopilaris

      Active, not recruiting
      • Lichen Planopilaris of Scalp
      • +3 more
      • Boston Grade of Activity in Lichen Planopilaris
      • Boston, Massachusetts
        Massachusetts General Hospital
      Jan 24, 2022

      Radiation Dermatitis Trial in Chicago (Dilute Sodium Hypochlorite solution)

      Terminated
      • Radiation Dermatitis
      • Dilute Sodium Hypochlorite solution
      • Chicago, Illinois
        Northwestern University
      Aug 14, 2022

      NSCLC Trial (Amivantamab, Lazertinib, Doxycycline)

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • (no location specified)
      Nov 7, 2023

      Dermatomyositis, Adult Type Trial in New Orleans (Apremilast 30mg)

      Completed
      • Dermatomyositis, Adult Type
      • Apremilast 30mg
      • New Orleans, Louisiana
        Tulane University
      Jul 7, 2021

      Tolerance of JAK Inhibitors in ATU for Atopic Dermatitis

      Enrolling by invitation
      • Dermatitis, Atopic
        • Lisle-sur-Tarn, France
          Hop Claude Huriez Chu Lille
        May 27, 2021

        Sleep Apnea, Obstructive Trial in Lisbon (radiation, drug, device)

        Not yet recruiting
        • Sleep Apnea, Obstructive
        • Pharyngeal Computed Tomography
        • +2 more
        • Lisbon, Portugal
          CUF Tejo Hospital
        Feb 2, 2023

        Improvement and Quality of Life Trends for UK/ROI Patients

        Completed
        • Plaque Psoriasis
        • Secukinumab
        • East Hanover, New Jersey
          Novartis Investigative Site
        Jun 29, 2022

        Dermatologic Conditions Trial in Westford (Intense pulsed light., Radiofrequency microneedling device, Radiofrequency device)

        Recruiting
        • Dermatologic Conditions
        • Intense pulsed light.
        • +3 more
        • Westford, Massachusetts
          Cynosure
        Oct 26, 2023

        Myocardial Infarction Trial (eHealth-based cardiac rehabilitation)

        Not yet recruiting
        • Myocardial Infarction
        • eHealth-based cardiac rehabilitation
        • (no location specified)
        Jan 9, 2023

        Atopic Dermatitis Trial in Baltimore (Tencel Therapeutic Garments, Cotton Therapeutic Garments)

        Not yet recruiting
        • Atopic Dermatitis
        • Tencel Therapeutic Garments
        • Cotton Therapeutic Garments
        • Baltimore, Maryland
          Johns Hopkins Pediatric Dermatology Clinic
        Sep 8, 2021